Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)-Reference-Cited by-同舟云学术

Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)

Published:2006-06 Issue:1-2 Volume:175 Page:107-117
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Jha Smita,Xu Kaiping,Maruta Takahiro,Oshima Minako,Mosier Dennis R.,Atassi M. Zouhair,Hoch Werner

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference46 articles.

1. Three forms of immune myasthenia;Agius;Ann. N.Y. Acad. Sci.,2003

2. Molecular recognition of acetylcholine receptor. Recognition by α-neurotoxins and by immune and autoimmune responses and manipulation of the responses;Atassi;Adv. Neuroimmunol.,1995

3. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides;Atassi;Crit. Rev. Immunol.,1997

4. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by an mPEG conjugate of a myasthenogenic synthetic peptide;Atassi;Proc. Natl. Acad. Sci. U. S. A.,1992

5. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against MHC peptide region involved in the presentation of a pathogenic T cell epitope;Atassi;Crit. Rev. Immunol.,2001

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myasthenia gravis;Handbook of Clinical Neurology;2024

2. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease;Frontiers in Immunology;2023-07-26

3. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells;Nature Biotechnology;2023-01-19

4. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis;Proceedings of the National Academy of Sciences;2021-03-22

5. Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis;2020-09-24